None listed
Conditions
Interventions
Intervention1: Eltior Skin-Barrier Moisturizer: Mfg by: Zymo Cosmetics
Marketed By: Relaner Ventures Pvt. Ltd.
Mode of Usage: Apply the moisturizer evenly using gentle circular motions. Do not massa
Sponsors
Relaner Ventures Pvt. Ltd.
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age: 18 to 55 years at the time of consent. 2.Sex: Healthy males and non-pregnant, non-lactating female participants having oily, dry, normal, sensitive or combination skin type. 3.Females of childbearing potential should have a self-reported negative urine pregnancy test at the time of screening visit. 4.Participants forearm must be free of cuts, tattoos, scratches, abrasions, scars, uneven skin tone, sunburn, excessive tan, excessive hair or open wounds on or near the test sites. 5.If the participant is of childbearing potential, is practicing and agrees to maintain an established method of birth control (IUD, hormonal implant device/injection, regular use of birth control pills or patch, diaphragm, condoms with spermicide or sponge with spermicidal jelly, cream or foam, partner vasectomy or abstinence). Females will be considered as non-childbearing potential if they are surgically sterile, have been post-menopausal for at least 1 year or have had a tubal ligation. 6.Participants who commit not to use medicated skincare products other than the test product for the entire duration of the study. 7.Participants are not allowed to participate in any other study until this study is complete. 8.Patients are willing to give written informed consent and are willing to come for regular follow up. 9.Participants must agree to record each use of the test products in the participant s diary card on daily basis. 10.Participant who have not participated in a similar study in the past three months.
Exclusion criteria
Exclusion criteria: 1.Participants with other dermatologic diseases whose presence or treatments could interfere with the assessment of study. 2.Participants that are pregnant and/or breastfeeding. 3.The participant has a known allergy or sensitivity to any cosmetic product. 4.The participant has any other skin conditions i.e. cuts, scratches, ring worms, etc. which in the opinion of the Investigator, will interfere with the study results or will create undue risk for the participant. 5.The participant is currently taking or has taken any medication, which the Investigator believes may influence the interpretation of the data. 6.History of chronic illness which may influence the cutaneous state.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To evaluate the effectiveness of the test product in terms of change in skin hydration using Corneometer CM 825. 2.To evaluate the effectiveness of the test product in terms of change in skin barrier function using Tewameter TM Hex. 3.To evaluate the effect of test product in terms of repair skin barrier damage following standardized tape stripping induced barrier disruption using Tewameter TM Hex and Corneometer CM 825. Timepoint: Baseline before usage of the test product on Day 01 and after usage of the test product at T20 min on Day 01, Day 02 and Day 15 ( 2 Days). | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the effectiveness of the test product in terms change in skin texture i.e., skin smoothness, skin dryness, skin roughness and skin scaliness using Visioscan VC 20 Plus.Timepoint: Baseline before usage of the test product on Day 01 and after usage of the test product at T20 min on Day 01, Day 02 and Day 15 ( 2 Days).;To evaluate the effectiveness of test product in terms of change in visual and tactile assessment of skin including skin scaliness, skin roughness, skin redness, skin itchiness, skin dryness and skin smoothness by dermatologist trained evaluator or dermatologistTimepoint: Baseline (Day 01) before usage of test product and after usage of test product at T20 min on Day 01, Day 02 and Day 15 ( 2 Days).;To evaluate the effectiveness of test product in terms of change in total acne lesion using Visiopor PP34N.Timepoint: Baseline (Day 01) before usage of test product and after usage of test product at T20 min on Day 01, Day 02 and Day 15 ( 2 Days).;To evaluate the effectiveness of test product in terms of change in comedones by dermatologist trained evaluator or dermatologist.Timepoint: Baseline (Day 01) before usage of test product and after usage of test product at T20 min on Day 01, Day 02 and Day 15 ( 2 Days).;To evaluate the effectiveness of test product in terms of Visual Analogue Scale for itching and redness.Timepoint: Baseline (Day 01) before usage of test product and after usage of test product at T20 min on Day 01, Day 02 and Day 15 ( 2 Days).;To evaluate the effectiveness of test product in terms of change in appearance through digital photographs by Nikon Digital Camera D3300.Timepoint: before tape stripping and after tape stripping on Day 01 and after test product usage at T20min, Day 02 and Day 15 ( 2 Days).;To evaluate the effectiveness of test product by assessing change in subjective product perception questionnaire through 5-point Likert scale.Timepoint: From baseline on Day 01 and product usage at T 20min, Day 02 and Day 15 ( 2 | — |
Countries
India
Contacts
Public ContactDr Maheshvari Patel
NovoBliss Research Private Limited
Outcome results
None listed